ASPIRE-Hemophilia Regional Apply

Applicants

To be eligible for a Regional Haemophilia ASPIRE Research Awards, applicants must have a professional degree (MD, PhD, PharmD or equivalent). Investigators must be qualified to carry out the proposed investigation. Assessments of investigator qualification will be made on the basis of their commitment to research in this area, a dedicated faculty assignment and previous research and publication experience. They also need to reside in one of the following countries: Australia, Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Finland, Kyrgyzstan, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Japan, Mongolia, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK, Ukraine

Wave 3 Timeline

  • Application Deadline: 18th December 2017
  • Award Announcement: March 2018
  • Project Start Date: October 2018
  • Project Duration: ≤18 months

How to Apply

Applications should be submitted through Pfizer’s global investigator-initiated research website. Please click on the link below, select “Submit an IIR Request,” and follow the online instructions. If this is your first time visiting the portal, you must first “Create an Account.”

Please select 2017 ASPIRE Haemophilia Wave 3 from the competitive programme drop-down. The system will automatically populate the study title with correct programme ID.

Completed application forms must be accompanied by the following documents:
  • Cover letter on institution letterhead
  • Relevant articles from the applicant’s scientific publications (if applicable)
  • Abbreviated curriculum vitae (CV) (limited to 3 pages)
  • Bibliography of relevant references
  • Itemized budget for proposed research
  • Finalised protocol
  • Informed consent and privacy authorisation
  • Description of requested support

Click here to apply for a 2017 regional ASPIRE haemophilia research award and access the Pfizer Investigator-Initiated Research site


Questions

Please see the Frequently Asked Questions (FAQ) page for help.

You may also e-mail questions to questions.europeaspire@pfizer.com

 

 

PP-GIP-EUR-1106
Date of preparation: November 2017